Drugs made of mRNA have the potential to transform medicine—if only they could get into cells in one piece. Now, University of Connecticut researchers have shown that packaging mRNA like a virus could ...

Kymera Therapeutics develops targeted protein degradation therapies for immunology, oncology, and fibrosis using proprietary technology.

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

The most reliable method is a short, realistic check of your usual intake. Choose 2–3 typical days (training and non-training ...

Net cash used in operating and investing activities was $23.3 million and $163.7 million for the fourth quarter and full year ...

From viral skillet cookies and protein bagels to truffle popcorn and new coffee creamer, these new Target grocery finds just ...

Scientists show that neutralizing liver-derived ApoE protein reverses age-related delays in bone fracture healing ...

Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a ...

Carfilzomib prevented BCMA degradation, increased target density, and improved CAR T susceptibility by ~26%–28% in vitro, while enhancing xenograft antitumor activity without worsening T-cell ...

After fulfilling its 2025 target of aligning its sales with the Dutch dietary guidelines, Lidl Netherlands has set a new goal ...

LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...

Recently, a collaborative effort among research centers in the United States and Europe resulted in the development of fibroblast activation protein reporting and data system (FAP-RADS) version 1.0, a ...